EU gives green light to new drug to treat endometrial cancer

The new drug treatment for uterine cancer, which is already in use in France on an early access scheme, will be used in combination with chemotherapy. British pharmaceutical company GlaxoSmithKline (GSK) announced on Monday that it has received European approval to market its treatment for…#gsk #europeancommission #jemperli
Source: Reuters: Health - Category: Consumer Health News Source Type: news